Design, synthesis, and biological evaluation of 4-arylmethyl-1-phenylpyrazole and 4-aryloxy-1-phenylpyrazole derivatives as novel androgen receptor antagonists
Satoshi Yamamoto(Takeda (Japan)), Mitsuhiro Ito(Takeda (Japan)), Atsushi Hasuoka(Takeda (Japan)), Tomohiko Suzaki(Takeda (Japan)), Naoyuki Kanzaki, Takahito Hara(Takeda (Japan)), Yuri Suzuki(Takeda (Japan)), Naoki Tomita(Takeda (Japan)), Atsuo Baba(Takeda (Japan)), Masuo Yamaoka, Tomohiro Kaku(Takeda (Japan))
Cited by 28
Related Papers
Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome.
|PubMed|2003|427
Discovery of TAK-981, a First-in-Class Inhibitor of SUMO-Activating Enzyme for the Treatment of Cancer
|Journal of Medicinal Chemistry|2021|205
Inhibition of GCN2 sensitizes ASNS-low cancer cells to asparaginase by disrupting the amino acid response
|Proceedings of the National Academy of Sciences|2018|172
Studies on Disease-Modifying Antirheumatic Drugs: Synthesis of Novel Quinoline and Quinazoline Derivatives and Their Anti-inflammatory Effect
|Journal of Medicinal Chemistry|1996|151